Markus Wallner

2.3k citations
81 papers · 1.7k · 1 hit paper · h-index 22

Impact in

Papers in

Markus Wallner

74 papers receiving 1.7k citations

Markus Wallner's Hit Papers

Empagliflozin in acute myocardial infarction: the EMMY trial 2022 · 220 citations
2200+1+2Years since publication50100150200

Peers

Markus Wallner
Comparison fields: 5 of 106
  • Cardiology and Cardiovascular Medicine 704
  • Endocrinology, Diabetes and Metabolism 373
  • Molecular Biology 518
  • Sensory Systems 35
  • Surgery 237
Replace Yung‐Kuo Lin with:
Yung‐Kuo Lin Taiwan
Gloria Färber Germany
Arnon Blum Israel
Jeong Euy Park South Korea
Lars Grip Sweden
Yi‐Da Tang China
Hirofumi Tomita Japan
Qiang She China
Antigoni Miliou Greece
Daiju Fukuda Japan
Markus Wallner relative to Yung‐Kuo Lin Taiwan Yung‐Kuo Lin's profile →
Citations per field
00.5×1.5×2.0×
Yung‐Kuo Lin · 1×
Citations per year

Countries citing papers authored by Markus Wallner

Since Specialization
Citations

This map shows the geographic impact of Markus Wallner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Wallner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Wallner more than expected).

Fields of papers citing papers by Markus Wallner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Wallner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Wallner. The network helps show where Markus Wallner may publish in the future.

Co-authors

The 25 scholars most cited alongside Markus Wallner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Markus Wallner Line = papers co-authored together Markus Wallner links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Empagliflozin in acute myocardial infarction: the EMMY trial
Hit paper breakdown →
2022220
2 2018190
3 202091
4 201381
5 201675
6 201562
7 201860
8 201854
9 202054
10 201246
11 202044
12 201742
13 201741
14 202039
15 202134
16 201733
17 201931
18 201930
19 201828
20 202325

About Markus Wallner

Markus Wallner is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Molecular Biology, Surgery and Pathology and Forensic Medicine, having authored 81 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (15 papers), Diabetes Treatment and Management (14 papers), Heart Failure Treatment and Management (11 papers), Cardiac Structural Anomalies and Repair (5 papers), Cardiac electrophysiology and arrhythmias (5 papers), Mechanical Circulatory Support Devices (4 papers), Cardiac Ischemia and Reperfusion (4 papers) and Cardiomyopathy and Myosin Studies (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (704 citations), Endocrinology, Diabetes and Metabolism (373 citations), Molecular Biology (518 citations), Sensory Systems (35 citations) and Surgery (237 citations). Markus Wallner has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Dirk von Lewinski, Steven R. Houser, Deborah Eaton, Harald Sourij, Giulia Borghetti, Ewald Kolesnik, Claudio de Lucia, Peter P. Rainer, Huaqing Zhao and Remus M. Berretta. Their work appears in journals such as Circulation Research, Scientific Reports, Journal of Clinical Medicine, ESC Heart Failure and Cardiovascular Diabetology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact